FDA Inspection 681951 — Abryrx, Inc.

Abryrx, Inc. — FEI 3005972619

The FDA completed an inspection of Abryrx, Inc. on Sep 9, 2010 in Irvington, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 9, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Irvington, NY (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
294921 CFR 812.46(a)Sponsor securing investigator compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.